C. Kreilick

Cost of atrial fibrillation in United States managed care organizations

Jay Lin, Mohamed Hussein, C. Kreilick et al. · Advances in Therapy · 2009 · 85 citations

Public Affairs, Cardiology, Pharmacoeconomics +16

Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co‐administered with metformin

Lawrence Blonde, Jenifer Wogen, C. Kreilick et al. · Diabetes Obesity and Metabolism · 2003 · 75 citations

Medicine, Pharmacology, Pharmacotherapy +17

Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes

Steven Deitelzweig, Jay Lin, C. Kreilick et al. · Advances in Therapy · 2010 · 48 citations

Medicine, Internal Medicine, Pharmacotherapy +15

The cost to managed care of managing pulmonary hypertension

Qayyim Said, Bradley C. Martin, Vijay N. Joish et al. · Journal of Medical Economics · 2012 · 43 citations · Full text

Medicine, Internal Medicine, Pharmacoeconomics +16

Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed

Stephen J. Boccuzzi, John Martin, Judith Stephenson et al. · Current Medical Research and Opinion · 2009 · 30 citations

Pharmacy, Cardiology, Pharmacoeconomics +17